Tirzepatide is a dual-agonist that targets the GIP and GLP-1 receptors, while retatrutide is a tri-agonist, targeting the GIP, GLP-1, and glucagon receptors for a broader effect on metabolism and energy expenditure
FCPS: Can in-network providers balance bill after allowed benefit amounts are paid
This peptide has been explored in cellular signalling research focused on cytoprotection, cell proliferation, and inflammation pathways (Wikipedia: BPC-157)
In short, human tissues, blood, and urine contain a mixture of arsenic metabolites that vary in acute and chronic toxicity
Mounjaro and GLP-1/GIP Receptor Agonists: Newer Hormonal Approach Mounjaro (tirzepatide) represents a newer class that mimics two natural gut hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)